The First People's Hospital of Yunnan Province
Welcome,         Profile    Billing    Logout  
 117 Trials 
867 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhang, Hong
NCT03431428: Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients

Recruiting
3
477
RoW
transanal surgery, Miles surgery, Preoperative chemoradiotherapy
Zhang Rui
Almost-cCR, Surgery, Rectal Cancer
01/20
12/22
CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE)

Completed
3
1412
RoW
Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA
Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital
Acute Ischemic Stroke
06/23
06/23
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
3
163
RoW
Lotilaner, TP-03, S-Misoxam, Vehicle Control
LianBio LLC
Blepharitis
09/23
04/24
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-Ⅲ)

Recruiting
3
1630
RoW
Alteplase, rt-PA, Tenecteplase, TNK-tPA
Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd
Acute Ischemic Stroke
11/23
03/24
TQC2731-III-01, NCT06829784: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Not yet recruiting
3
660
RoW
TQC2731 injection, Placebo
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Asthma
06/27
06/27
TaLaR-02, NCT05984485: The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer

Recruiting
3
766
RoW
neoadjuvant chemotherapy plus total mesorectal excision, total mesorectal excision
Sun Yat-sen University
Rectal Cancer
07/28
07/28
NCT05702489: A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

Completed
2/3
900
RoW
ZX-7101A
Nanjing Zenshine Pharmaceuticals
Influenza, Human
05/23
10/23
NCT04398459: The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Active, not recruiting
2
18
RoW
Ibrutinib, BTK inhibitor
Institute of Hematology & Blood Diseases Hospital, China
Refractory/Relapsed Autoimmune Hemolytic Anemia
12/24
06/25
NCT05292196: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Recruiting
2
460
RoW
TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Obstructive Pulmonary Disease (COPD)
01/24
05/24
NCT06670352: Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN

Recruiting
2
80
RoW
Placebo, HSK39297 50mgBID, HSK39297 100mgBID, HSK39297 200mgQD
Haisco Pharmaceutical Group Co., Ltd.
IgA Nephropathy (IgAN)
11/25
03/26
BID-PERAL, NCT04423367: Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

Completed
2
18
RoW
bortezomib/dexamethasone
Institute of Hematology & Blood Diseases Hospital, China
Acquired Pure Red Cell Aplasia
07/24
09/24
NCT05660785: Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia

Completed
2
54
RoW
Herombopag, Cyclosporine A
Institute of Hematology & Blood Diseases Hospital, China, Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Non Severe Aplastic Anemia, Untreated
01/25
01/25
NCT06687174: Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Not yet recruiting
2
72
RoW
MY008211A tablets, MY008211A tablets matched placebo
Wuhan Createrna Science and Technology Co., Ltd
IgA Nephropathy (IgAN)
06/26
01/28
NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Not yet recruiting
2
168
RoW
TQH2722 injection, TQH2722 Placebo
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Seasonal Allergic Rhinitis
06/25
08/25
NCT04688736: Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

Recruiting
2
6642
RoW
Placebo, Chlorpheniramine
Institute of Hematology & Blood Diseases Hospital, China
Allergic Transfusion Reaction
12/25
06/26
NCT06774664: A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases

Not yet recruiting
1/2
99
RoW
SCTC21C
Sinocelltech Ltd.
IgA Nephropathy
09/27
03/29
NCT04481841: Head Yuanshi Dian Therapy in Burning Mouth Syndrome

Recruiting
1
290
RoW
oryzanol + vitamin B2 (riboflavin) + vitamin E, head yuanshi dian therapy
Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Hospital of TCM, Guiyang Hospital of Stomatology
Burning Mouth Syndrome, Oral Mucosa Disease
02/22
05/22
NCT06101316: A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China

Recruiting
1
12
RoW
CB06-036
Shanghai Zhimeng Biopharma, Inc.
Healthy Volunteers
10/23
12/23
NCT06216041: To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

Recruiting
1
138
RoW
IMM-H014, Placebo, IMM-H014 ( FE), Placebo ( FE)
Changchun Intellicrown Pharmaceutical Co. LTD
Nonalcoholic Steatohepatitis (NASH)
07/24
12/24
NCT06160895: A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects

Completed
1
40
RoW
TQ-A3334 tablets, TQ-A3334 placebo tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Hepatitis B
06/24
08/24
NCT06427681: An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

Not yet recruiting
1
40
NA
BH006 for injection, Fosaprepitant for injection+Palonosetron hydrochloride injection, EMEND®+PALONOSETRON
Zhuhai Beihai Biotech Co., Ltd
Bioavailability
09/24
12/24
AP303-PK-03, NCT06666283: A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients

Not yet recruiting
1
18
NA
AP303 150μg, AP303 300μg, Placebo 150μg, Placebo 300μg
Alebund Pharmaceuticals
Diabetic Kidney Disease
01/25
01/25
NCT03806621: Rota China Registry

Completed
N/A
980
RoW
Rotational Atherectomy
Beijing Anzhen Hospital, BSC International Medical Trading (Shanghai) Co., Ltd.
Coronary Artery Disease
12/20
01/22
UltraFuture I, NCT05498740: Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

Recruiting
N/A
200
RoW
Drug eluting Balloon
Zhejiang Zylox Medical Device Co., Ltd.
Peripheral Arterial Disease (PAD)
12/22
12/24
NCT05608980: 0.01% Hypochlorous Acid in the Treatment of Blepharitis

Recruiting
N/A
100
RoW
0.01% hypochlorous acid, 0.01%HOCI, Placebo
Eye & ENT Hospital of Fudan University, ShuGuang Hospital
Blepharitis
12/22
05/23
NCT05685966: Retrospective Study of COVID-19 on Reproductive Function

Recruiting
N/A
400
RoW
no intervention
Jinling Hospital, China
COVID-19
03/23
01/24
NCT04852406: Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

Recruiting
N/A
526
RoW
Protocol-based management of perioperative antithrombotic therapy, Protocol-based management, Routine management of perioperative antithrombotic therapy, Routine management
Peking University First Hospital
Antithrombotic Therapy, Perioperative Care, Perioperative Outcomes
12/23
01/24
NCT05685992: Novel Coronavirus Infection and Reproductive Function

Recruiting
N/A
400
RoW
no intervention
Jinling Hospital, China
COVID-19 Infection
01/24
01/24
CSILS, NCT04527861: Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Recruiting
N/A
710
RoW
Single-incision Laparoscopic Surgery, SILS, Conventional Laparoscopic Surgery, CLS
Ruijin Hospital, Dongfang Hospital Affiliated to Tongji University, Fudan University, Changhai Hospital, Shengjing Hospital, RenJi Hospital, Liaoning Cancer Hospital & Institute, Zhejiang Provincial People's Hospital, Shandong Provincial Hospital, The General Hospital of Western Theater Command, Shanghai Jiao Tong University School of Medicine
Colorectal Cancer, Colon Cancer, Rectal Cancer
04/24
04/29
NCT04645810: A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Recruiting
N/A
12
US
High-Dose-Rate Brachytherapy
University of Rochester
Prostate Cancer, HDR
05/26
05/27
SCDB, NCT06422845: Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis

Recruiting
N/A
328
RoW
Dissolve AV Peripheral Scoring Drug-coated Balloon, Scoring Drug-coated Balloon
DK Medical Technology (Suzhou) Co., Ltd.
Arteriovenous Fistula Stenosis
07/27
07/27
TaLaR, NCT02966483: Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Recruiting
N/A
1114
RoW
TaTME, Transanal TME, LpTME, Laparoscopic TME
Sun Yat-sen University, Peking Union Medical College Hospital, The First Hospital of Jilin University, RenJi Hospital, Shengjing Hospital, The Second People's Hospital of Yibin, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Nanchong Central Hospital, Zunyi Medical College, The First Affiliated Hospital of University of South China, Xinqiao Hospital, Nanfang Hospital, Southern Medical University, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, Affiliated Hospital of Guangdong Medical University, The Third Xiangya Hospital of Central South University
Rectal Neoplasms Malignant, Surgery
07/26
07/26
mLOWER, NCT02693496: Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research

Recruiting
N/A
10000
RoW
Installation or registration of smartphone application
Chinese Alliance Against Lung Cancer
Solitary Pulmonary Nodule
10/25
10/25
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting
N/A
2150
RoW
Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Heart Disease
01/26
01/28
FLORA-01, NCT05730595: Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer

Not yet recruiting
N/A
550
RoW
lymph node dissection, Fluorescence-guided laparoscopic surgery, Radical operation for rectal cancer and sigmoid Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Fudan University, Fujian Province Tumor Hospital, Guangdong Provincial People's Hospital, Shengjing Hospital, Affiliated Hospital of Qinghai University, Hebei Medical University Fourth Hospital, The Second Affiliated Hospital of Harbin Medical University, Jiangxi Provincial Cancer Hospital, The First Hospital of Jilin University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanxi Province Cancer Hospital, Nanfang Hospital, Southern Medical University, Second People's Hospital of Yunnan Province, Binzhou Medical University, The First Affiliated Hospital of University of Science and Technology of China, First Affiliated Hospital of Chengdu Medical College, The Second People's Hospital of Yibin, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Colorectal Neoplasms, Fluorescence, Lymph Node Excision
12/26
06/27
TESTING-ON, NCT05434325: TESTING -ON Post-Trial ObservatioNal Cohort Study

Recruiting
N/A
366
Canada, RoW
The George Institute, Peking University Institute of Nephrology
IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases
07/27
07/27
Lu, Ying
FUMANBA-03, NCT06464991: A Phase III Study of Eque-cel in Subjects with Len-refractory RRMM

Recruiting
3
240
RoW
Equecabtagene Autoleucel Injection, FUCASO, Daratumumab, Pomalidomide, Bortezomib, Dexamethasone
Nanjing IASO Biotechnology Co., Ltd.
Multiple Myeloma
08/27
12/30
NCT06520176: Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Recruiting
3
99
RoW
Etoposide, VP-16, Cytarabine, Ara-C, Pegfilgrastim, PEG-rhG-CSF, Cyclophosphamide, Cy, G-CSF, Granulocyte Colony Stimulating Factor
The Affiliated People's Hospital of Ningbo University, First Affiliated Hospital of Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, The Central Hospital of Lishui City, Jinhua People's Hospital, Shaoxing People's Hospital, Shaoxing Second Hospital, Zhejiang Provincial Tongde Hospital, Taizhou Hospital, Dongyang People's Hospital, Affiliated Hospital of Jiaxing University, Huizhou Municipal Central Hospital, Second Affiliated Hospital of Wenzhou Medical University, Ningbo Medical Center Lihuili Hospital, Jinhua Municipal Central Hospital
Multiple Myeloma, Hematopoietic Stem Cell Mobilization
12/26
12/26
NCT06520163: Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Recruiting
3
99
RoW
Etoposide, VP-16, Cytarabine, Ara-C, PEG-rhG-CSF, G-CSF, CHOP, Hyper-CVAD, ID-MTX + Ara-C, DA-EPOCH, GDP, GDPE, ICE, DICE
The Affiliated People's Hospital of Ningbo University, First Affiliated Hospital of Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Jinhua People's Hospital, The Central Hospital of Lishui City, Shaoxing People's Hospital, Shaoxing Second Hospital, Zhejiang Provincial Tongde Hospital, Taizhou Hospital, Dongyang People's Hospital, Affiliated Hospital of Jiaxing University, Huizhou Municipal Central Hospital, Second Affiliated Hospital of Wenzhou Medical University, Ningbo Medical Center Lihuili Hospital, Jinhua Municipal Central Hospital
Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization
12/26
12/26
TQ05105-III-01, NCT06682169: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Recruiting
3
182
RoW
Rovadicitinib, Imatinib, Methotrexate, Mycophenolate mofetil, Rituximab
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Graft-versus-host Disease
10/29
12/30
NCT05780372: Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Recruiting
3
474
RoW
Intensity Modulated Radiation Therapy, IMRT, Chemotherapy
Sun Yat-sen University, Jiangxi Provincial Cancer Hospital, Zhejiang Cancer Hospital, Chongqing University Cancer Hospital, Dongguan People's Hospital, LiuZhou People's Hospital
Nasopharyngeal Carcinoma, Radiotherapy; Complications
05/25
05/28
NCT05084027: Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Recruiting
2
50
RoW
venetoclax combining with fludarabine and melphalan
First Affiliated Hospital of Zhejiang University, Sir Run Run Shaw Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial People's Hospital, The affiliated people's hospital of Ningbo University, First Affiliated Hospital of Wenzhou Medical University, Ningbo Hospital of Zhejiang University, The First Affiliated Hospital of Zhejiang Chinese Medical University
Hematologic Malignancy, Older Patients, Allogeneic Hematopoietic Stem Cell Transplantation
09/22
09/24
NCT06300320: A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Recruiting
2
52
RoW
TQ05105 tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Graft Versus Host Disease
10/25
04/26
NCT06455410: GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma

Recruiting
2
216
RoW
GP, Adebrelimab, concurrent chemoradiotherapy (CCRT)
Sun Yat-sen University
Nasopharyngeal Carcinoma
06/26
06/28
NCT03118986: RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Recruiting
2
200
Canada, US, RoW
Olanzapine, Placebo Oral Tablet
The Hospital for Sick Children, University of California, San Francisco, Children's Mercy Hospital Kansas City, St. Justine's Hospital, Columbia University, Medical University of South Carolina, CancerCare Manitoba, University of North Carolina, Chapel Hill, Nationwide Children's Hospital
Vomiting in Infants and/or Children, Nausea, Hematopoietic System--Cancer, Oncology
03/25
04/25
NCT05422066: Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma

Hourglass Jan 2023 - Dec 2023 : Market entry for endometrial cancer
Recruiting
2
50
RoW
Selinexor, ATG-010, Xpovio, Rituximab, RiTUXimab Injection, Cyclophosphamide, Cyclophosphamide Injection, Doxorubicin, Doxorubicin Hydrochloride, Vincristine, Vincristine Injection, Prednisone, Prednisone Oral Product
Li Zhiming, Antengene Corporation
DLBCL Germinal Center B-Cell Type
07/25
12/25
NCT05842512: Study of ADI-PEG 20 Versus Placebo in Subjects With NASH

Recruiting
2
40
RoW
ADI-PEG20, Pegargiminase, Placebo
Polaris Group
Nonalcoholic Steatohepatitis (NASH)
12/27
01/28
NCT02617407: Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

Completed
1
44
US
Livionex® Dental Gel, Edathamil, PreviDent 5000 plus/Tom's of Maine Children's toothpaste, Over the counter toothpaste, Kolibree Toothbrush
University of California, San Francisco
Dental Plaque
01/20
01/20
NCT05528887: Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Recruiting
1
10
RoW
Autologous CAR-T cells, Fludarabine, Fludara, Cyclophosphamide, Cytoxan
The Affiliated People's Hospital of Ningbo University, UTC Therapeutics Inc.
Relapsed/Refractory Hematological Malignancies, Lymphoma, Myeloma, Leukemia
06/24
06/26
NCT06142175: Relmacabtagene Autoleucel in Patients With LBCL

Recruiting
N/A
200
RoW
Relmacabtagene Autoleucel, JWCAR029
Shanghai Ming Ju Biotechnology Co., Ltd.
Large B-cell Lymphoma
12/24
12/24
NCT05510089: Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies

Recruiting
N/A
62
RoW
Etoposide, VP-16, Cytarabine, Ara-C, PEG-rhG-CSF
The Affiliated People's Hospital of Ningbo University
Hematological Malignancy
05/24
12/24
2022-YAN-030, NCT05536154: Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

Recruiting
N/A
68
RoW
Etoposide, VP-16, Cytarabine, Ara-C, PEG-rhG-CSF
The Affiliated People's Hospital of Ningbo University
Lymphoma, Multiple Myeloma
06/24
10/24
NCT05589337: Baduanjin Training for Depression and Anxiety Patients

Recruiting
N/A
120
RoW
Baduanjin, Eight-section Brocade, Health education
Shanghai University of Traditional Chinese Medicine, Shanghai Mental Health Center
Depression Symptoms, Anxiety Symptoms
06/24
12/24
NCT05717790: Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Recruiting
N/A
288
RoW
Nimotuzumab, h-R3, BIOMAb EGFR, Gemcitabine, GEM, Cisplatin, DDP, Intensity-modulated radiotherapy, IMRT
Fourth Affiliated Hospital of Guangxi Medical University, People's Hospital of Baise, Second Affiliated Hospital of Guangzhou Medical University, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin Medical University, China, LiuZhou People's Hospital, The First People's Hospital of Qinzhou, Wuzhou Red Cross Hospital, Affiliated Hospital of Youjiang Medical University for Nationalities
Nasopharyngeal Carcinoma by AJCC V8 Stage
11/24
11/27
NCT04837222: A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

Active, not recruiting
N/A
1000
RoW
No Intervention
Takeda
Lymphoma
06/26
06/26
NCT05355675: The Association of Microbiota Composition With cGVHD After Allo-HSCT

Recruiting
N/A
300
RoW
blood sample, stool sample
First Affiliated Hospital of Zhejiang University
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy, Chronic Graft-versus-host-disease, Complication
05/25
05/25
NCT05940480: TCM Daoyin Therapy in Individuals At-risk for COPD

Recruiting
N/A
60
RoW
TCM Daoyin, Qigong, Health education
Shanghai University of Traditional Chinese Medicine, Changzheng Community Health Service Center of Putuo District, Shanghai
Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
06/27
12/27
Chen, Yundai
Health, NCT06187727: Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction

Recruiting
4
240
RoW
Henagliflozin
Qian geng
Myocardial Infarction, Heart Failure
10/24
10/24
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
539
RoW
BuMA Supreme, BuMA™
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
03/18
12/25
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
1000
RoW
BuMA Supreme
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
05/19
12/25
NCT04220437: Identification of Neoatherosclerosis in ISR Patients Based on Artifical Intelligence

Recruiting
N/A
90
RoW
no interventin
Chinese PLA General Hospital
In-stent Restenosis, Neo-atherosclerosis, Retrospective
01/21
02/21
NCT03574636: OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation

Recruiting
N/A
375
RoW
OCT guidance, IVUS guidance, QCA
Shanghai MicroPort Medical (Group) Co., Ltd.
Optical Coherence Tomography, Intravascular Ultrasound, Angiography
09/21
09/25
SUPERIOR, NCT04617899: The StUdy to Evaluate the Performance and safEty of the Novasight HybRid System Using Objective PeRformance Criteria

Recruiting
N/A
120
RoW
Intravascular imaging
CardioNavi MedTech (Wuhan) Co., Ltd., Beijing Jingruitianhe Medical Science and Technology Development Co,Ltd
Coronary Artery Disease
11/21
12/21
NCT04733443: The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis

Active, not recruiting
N/A
310
RoW
Biolimus, SeQuent® Please Neo
JW Medical Systems Ltd
Coronary Artery Disease
01/23
02/25
NCT04982588: Evolut PRO China Clinical Study

Active, not recruiting
N/A
52
RoW
Medtronic CoreValve™ Evolut™ PRO System
Medtronic Cardiovascular
Severe, Symptomatic Aortic Stenosis
03/23
05/28
NCT05580952: Clinical Trial in China

Recruiting
N/A
120
RoW
Transcatheter aortic valve replacement
Genesis Medtech Corporation
Diseases of Aortic Valve, Aortic Regurgitation Disease
05/23
05/24
NCT05607667: Clinical Trial in China for Aortic Valve Stenosis

Recruiting
N/A
53
RoW
Transcatheter aortic valve replacement
Genesis Medtech Corporation
Diseases of Aortic Valve, Aortic Stenosis Disease
05/23
05/23
NCT04722796: HANGZHOU Solution in Bicuspid AS Undergoing TAVR

Recruiting
N/A
508
RoW
TAVR with Venus A plus using supra-annular sizing and THV implantation technique (Hangzhou solution), Hangzhou solution, TAVR with Venus A plus using annular sizing and THV implantation technique, Traditional sizing strategy (Annulus based sizing strategy)
Second Affiliated Hospital, School of Medicine, Zhejiang University, Venus MedTech (HangZhou) Inc., First Affiliated Hospital Bengbu Medical College, Chinese PLA General Hospital, Fujian Medical University Union Hospital, Xiamen University Affiliated Cardiovascular Hospital, Guangdong People's Hospital, Zhengzhou Cardiovascular Hospital, The First Affiliated Hospital of Zhengzhou University, Hennan Provincial Chest Hospital, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Central South University, Northern Jiangsu Province People's Hospital, The First Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Nanchang University, The Affiliated Hospital of Qingdao University, Shanxi cardiovascular hospital, Tianjin Chest Hospital, Ning Bo First Hospital
Aortic Stenosis, Aortic Stenosis With Bicuspid Valve
04/24
04/28
NCT05454878: Atrial Fibrillation Monitoring on Patients With Lymphoma After Chemotherapy

Not yet recruiting
N/A
100
RoW
Chinese PLA General Hospital
Atrial Fibrillation
07/23
12/23
Wang, Yan
NCT06256289: Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

Not yet recruiting
4
50
NA
Canagliflozin 100mg Tab, Invokana, Metformin Hydrochloride, Glucophage
Ping Li,MD
Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease
04/25
04/25
NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Recruiting
3
450
RoW
camrelizumab + famitinib, pembrolizumab, camrelizumab
Jiangsu HengRui Medicine Co., Ltd.
Non-small Cell Lung Cancer
12/23
12/25
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Recruiting
3
522
RoW
D-1553 Tablet, Docetaxel injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
10/26
12/27
ASPIRE, NCT03907046: Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Recruiting
3
700
US
Apixaban, Eliquis, Aspirin
Yale University, National Institute of Neurological Disorders and Stroke (NINDS)
Intracerebral Hemorrhage, Atrial Fibrillation
04/27
04/27
SURPASS-CN-INS, NCT05691712: A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

Completed
3
257
RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Diabetes Type 2, Diabetes Mellitus, Glucose Metabolism Disorders, Metabolic Disease, Endocrine System Diseases
07/24
07/24
NCT06738979: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects

Not yet recruiting
3
408
RoW
TQF3510 (Semaglutide Injection), Wegovy®
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Obesity
07/26
08/26
TQB2450-AL2846-III-01, NCT05922345: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.

Recruiting
3
518
RoW
TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules, TQB2450 placebo, docetaxel injection, AL2846 matching placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non-small Cell Lung Cancer
08/25
12/25
CAPTIVA, NCT05047172: Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Recruiting
3
1683
US
Ticagrelor + Aspirin, Brilinta, Rivaroxaban + Aspirin, Xarelto, Clopidogrel + Aspirin, Plavix, Risk Factor Management
University of Florida, National Institute of Neurological Disorders and Stroke (NINDS), University of Cincinnati, Medical University of South Carolina, Janssen Scientific Affairs, LLC, AstraZeneca
Intracranial Arteriosclerosis, Stroke
05/28
05/28
NCT04412564: A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor

Recruiting
2
200
RoW
TQ-B3101
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Malignant Tumor
03/21
09/21
NCT04228926: Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects

Recruiting
2
105
RoW
ZKY001 eye drops 0.3g:0.006mg, shengfatai-eye drops, the Germinal Peptide eye drops, ZKY001 eye drops 0.3g:0.012mg, ZKY001 simulated eye drops, the placebo
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Corneal Defect
12/21
12/21
NCT05148195: A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors

Terminated
2
86
RoW
Envofolimab, BD0801, Docetaxel, Irinotecan, Leucovorin calcium, 5-Fluorouridine
Jiangsu Simcere Pharmaceutical Co., Ltd.
Advanced Solid Tumor
07/23
07/23
NCT05420324: A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma

Completed
2
20
RoW
YH003, Pembrolizumab, albumin paclitaxel
Eucure (Beijing) Biopharma Co., Ltd
Mucosal Melanoma
03/24
03/24
NCT06439381: Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps

Recruiting
2
120
RoW
300mg/600mg of TQH2722 injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Rhinosinusitis
10/25
11/25
NCT06837233: A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis

Not yet recruiting
2
160
RoW
Pumecitinib Nasal Spray 0.3%, Pumecitinib Nasal Spray 0.6%, Placebo (twice daily), Pumecitinib nasal spray 0.6%(twice daily), Placebo
Prime Gene Therapeutics Co., Ltd.
Seasonal Allergic Rhinitis
07/25
01/26
NCT06089278: A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.

Recruiting
2
160
RoW
300mg of TQH2722 injection, 600mg of TQH2722 injection, TQH2722 injection matching placebo
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Sinusitis
05/25
05/25
NCT04993391: AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer

Recruiting
1/2
156
RoW
JS111(AP-L1898 Capsules)
Suzhou Junjing BioSciences Co., Ltd.
Lung Cancer
06/24
08/24
NCT04434482: IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer

Completed
1/2
59
US, RoW
IMP4297(senaparib), temozolomide
Impact Therapeutics, Inc.
Advanced Solid Tumours, Small Cell Lung Cancer
04/24
04/24
NCT05416775: Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer

Recruiting
1/2
168
RoW
SHR-8068;Adebrelimab, SHR-8068;adebrelimab and platinum-based chemotherapy, Adebrelimab;platinum-based chemotherapy
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Advanced Non-small Cell Lung Cancer
06/26
06/26
NCT05126927: A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors

Completed
1
11
RoW
68Ga-NODAGA-SNA006
SmartNuclide Biopharma, The First Affiliated Hospital of Soochow University
Solid Tumor
01/22
08/22
NCT04711980: Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy

Not yet recruiting
1
402
RoW
Mudan granule, Mudan particle, Placebo, Placebos
Fengmei Lian, Peking Union Medical College Hospital, Beijing Hospital, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Affiliated Hospital of Qingdao University, Chengdu University of Traditional Chinese Medicine, The Fourth People's Hospital of Chongqing, Zhengzhou Yihe Hospital Affiliated to Henan University, Zhu Xianyi Memorial Hospital of Tianjin Medical University, The Third Hospital of Xi'an, Huashan Hospital, Gansu Provincial People's Hospital, Shenzhen Hospital of Guangzhou University of Traditional Chinese Medicine, Affiliated Hospital of Changchun University of Chinese Medicine
Diabetic Peripheral Neuropathy Type 2
02/22
09/22
NCT05490264: [68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

Recruiting
1
20
RoW
[68Ga]Ga-NOTA-SNA002
SmartNuclide Biopharma, The First Affiliated Hospital of Soochow University
Solid Tumor, Positron-Emission Tomography(PET)
06/24
07/24
NCT03736343: Impulsivity and Alcohol Response

Terminated
1
24
US
Alcohol, 80-proof Vodka Mixed Drinks
University of Florida, National Institute on Alcohol Abuse and Alcoholism (NIAAA), American Psychological Association
Alcohol Use Disorder (AUD), Subjective Response to Alcohol (SR)
05/20
10/22
NCT06429241: Evaluate the Distribution and Dynamic Behavior of TH-SC01 Cells in Vivo in Patients With Perianal Fistula

Recruiting
1
8
RoW
Mesenchymal Stem Cells (MSCs)
Jiangsu Topcel-KH Pharmaceutical Co., Ltd., The First Affiliated Hospital of Soochow University
Anal Fistula, Complex Perianal Fistulas, Crohn's Disease
11/24
12/25
NCT06229301: A Study of Artificial Intelligence Assisted Small Incision Lenticule Extraction (SMILE) for Surgical Design and Influencing Factors

Recruiting
N/A
3000
RoW
AI-predicted Nomogram
Tianjin Eye Hospital, Beihang University
Myopia, Myopic Astigmatism
09/24
09/24
NCT04172168: Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction (LVFR-AMI)

Recruiting
N/A
17568
RoW
Heart rupture
Xiamen Cardiovascular Hospital, Xiamen University
Acute Myocardial Infarction
12/19
03/21
STMIK, NCT06233409: A Novel Sandwich Technique of Minimally Invasive Keratoplasty for Corneal Perforation

Recruiting
N/A
30
RoW
Tianjin Eye Hospital
Corneal Perforation, Corneal Stromal Lenticule,Sandwich Technique
12/24
12/24
NCT06211218: Artificial Intelligence for Screening of Multiple Corneal Diseases

Recruiting
N/A
3000
RoW
Cornea diseases diagnosed by artificial intelligence algorithm
Tianjin Eye Hospital
Deep Learning, Corneal Disease, Screening
12/21
12/24
NCT04667819: Wireless Micropump in Dry Eye Patients

Recruiting
N/A
20
RoW
Sodium Hyaluronate
Tianjin Eye Hospital, Tianjin University
Dry Eye
12/21
03/22
NCT05967702: A 3-year Cross-sectional Assessment of the Tianjin Child and Adolescent Large-scale Eye Study

Completed
N/A
126810
RoW
Tianjin Eye Hospital
Myopia
12/21
12/21
NCT06256770: Evaluation of the Safety and Efficacy of Rigid Breathable Scleral Contact Lenses for the Correction of Ametropia

Recruiting
N/A
176
RoW
Tianjin Eye Hospital
Ocular Surface Disease, Irregular Astigmatism, Contact Lens Complication, Corneal Astigmatism
09/24
12/24
NCT05748002: Evaluation of Morphology Abnormal Cornea Stability With Corneal Biomechanical

Completed
N/A
315
RoW
Pentacam and Corvis ST
Tianjin Eye Hospital
Keratoconus, Stable
12/22
12/22
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhang, Hong
NCT03431428: Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients

Recruiting
3
477
RoW
transanal surgery, Miles surgery, Preoperative chemoradiotherapy
Zhang Rui
Almost-cCR, Surgery, Rectal Cancer
01/20
12/22
CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE)

Completed
3
1412
RoW
Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA
Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital
Acute Ischemic Stroke
06/23
06/23
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
3
163
RoW
Lotilaner, TP-03, S-Misoxam, Vehicle Control
LianBio LLC
Blepharitis
09/23
04/24
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-Ⅲ)

Recruiting
3
1630
RoW
Alteplase, rt-PA, Tenecteplase, TNK-tPA
Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd
Acute Ischemic Stroke
11/23
03/24
TQC2731-III-01, NCT06829784: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Not yet recruiting
3
660
RoW
TQC2731 injection, Placebo
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Asthma
06/27
06/27
TaLaR-02, NCT05984485: The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer

Recruiting
3
766
RoW
neoadjuvant chemotherapy plus total mesorectal excision, total mesorectal excision
Sun Yat-sen University
Rectal Cancer
07/28
07/28
NCT05702489: A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

Completed
2/3
900
RoW
ZX-7101A
Nanjing Zenshine Pharmaceuticals
Influenza, Human
05/23
10/23
NCT04398459: The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Active, not recruiting
2
18
RoW
Ibrutinib, BTK inhibitor
Institute of Hematology & Blood Diseases Hospital, China
Refractory/Relapsed Autoimmune Hemolytic Anemia
12/24
06/25
NCT05292196: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Recruiting
2
460
RoW
TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Obstructive Pulmonary Disease (COPD)
01/24
05/24
NCT06670352: Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN

Recruiting
2
80
RoW
Placebo, HSK39297 50mgBID, HSK39297 100mgBID, HSK39297 200mgQD
Haisco Pharmaceutical Group Co., Ltd.
IgA Nephropathy (IgAN)
11/25
03/26
BID-PERAL, NCT04423367: Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

Completed
2
18
RoW
bortezomib/dexamethasone
Institute of Hematology & Blood Diseases Hospital, China
Acquired Pure Red Cell Aplasia
07/24
09/24
NCT05660785: Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia

Completed
2
54
RoW
Herombopag, Cyclosporine A
Institute of Hematology & Blood Diseases Hospital, China, Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Non Severe Aplastic Anemia, Untreated
01/25
01/25
NCT06687174: Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Not yet recruiting
2
72
RoW
MY008211A tablets, MY008211A tablets matched placebo
Wuhan Createrna Science and Technology Co., Ltd
IgA Nephropathy (IgAN)
06/26
01/28
NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Not yet recruiting
2
168
RoW
TQH2722 injection, TQH2722 Placebo
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Seasonal Allergic Rhinitis
06/25
08/25
NCT04688736: Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

Recruiting
2
6642
RoW
Placebo, Chlorpheniramine
Institute of Hematology & Blood Diseases Hospital, China
Allergic Transfusion Reaction
12/25
06/26
NCT06774664: A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases

Not yet recruiting
1/2
99
RoW
SCTC21C
Sinocelltech Ltd.
IgA Nephropathy
09/27
03/29
NCT04481841: Head Yuanshi Dian Therapy in Burning Mouth Syndrome

Recruiting
1
290
RoW
oryzanol + vitamin B2 (riboflavin) + vitamin E, head yuanshi dian therapy
Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Hospital of TCM, Guiyang Hospital of Stomatology
Burning Mouth Syndrome, Oral Mucosa Disease
02/22
05/22
NCT06101316: A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China

Recruiting
1
12
RoW
CB06-036
Shanghai Zhimeng Biopharma, Inc.
Healthy Volunteers
10/23
12/23
NCT06216041: To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

Recruiting
1
138
RoW
IMM-H014, Placebo, IMM-H014 ( FE), Placebo ( FE)
Changchun Intellicrown Pharmaceutical Co. LTD
Nonalcoholic Steatohepatitis (NASH)
07/24
12/24
NCT06160895: A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects

Completed
1
40
RoW
TQ-A3334 tablets, TQ-A3334 placebo tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Hepatitis B
06/24
08/24
NCT06427681: An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

Not yet recruiting
1
40
NA
BH006 for injection, Fosaprepitant for injection+Palonosetron hydrochloride injection, EMEND®+PALONOSETRON
Zhuhai Beihai Biotech Co., Ltd
Bioavailability
09/24
12/24
AP303-PK-03, NCT06666283: A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients

Not yet recruiting
1
18
NA
AP303 150μg, AP303 300μg, Placebo 150μg, Placebo 300μg
Alebund Pharmaceuticals
Diabetic Kidney Disease
01/25
01/25
NCT03806621: Rota China Registry

Completed
N/A
980
RoW
Rotational Atherectomy
Beijing Anzhen Hospital, BSC International Medical Trading (Shanghai) Co., Ltd.
Coronary Artery Disease
12/20
01/22
UltraFuture I, NCT05498740: Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

Recruiting
N/A
200
RoW
Drug eluting Balloon
Zhejiang Zylox Medical Device Co., Ltd.
Peripheral Arterial Disease (PAD)
12/22
12/24
NCT05608980: 0.01% Hypochlorous Acid in the Treatment of Blepharitis

Recruiting
N/A
100
RoW
0.01% hypochlorous acid, 0.01%HOCI, Placebo
Eye & ENT Hospital of Fudan University, ShuGuang Hospital
Blepharitis
12/22
05/23
NCT05685966: Retrospective Study of COVID-19 on Reproductive Function

Recruiting
N/A
400
RoW
no intervention
Jinling Hospital, China
COVID-19
03/23
01/24
NCT04852406: Protocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy

Recruiting
N/A
526
RoW
Protocol-based management of perioperative antithrombotic therapy, Protocol-based management, Routine management of perioperative antithrombotic therapy, Routine management
Peking University First Hospital
Antithrombotic Therapy, Perioperative Care, Perioperative Outcomes
12/23
01/24
NCT05685992: Novel Coronavirus Infection and Reproductive Function

Recruiting
N/A
400
RoW
no intervention
Jinling Hospital, China
COVID-19 Infection
01/24
01/24
CSILS, NCT04527861: Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Recruiting
N/A
710
RoW
Single-incision Laparoscopic Surgery, SILS, Conventional Laparoscopic Surgery, CLS
Ruijin Hospital, Dongfang Hospital Affiliated to Tongji University, Fudan University, Changhai Hospital, Shengjing Hospital, RenJi Hospital, Liaoning Cancer Hospital & Institute, Zhejiang Provincial People's Hospital, Shandong Provincial Hospital, The General Hospital of Western Theater Command, Shanghai Jiao Tong University School of Medicine
Colorectal Cancer, Colon Cancer, Rectal Cancer
04/24
04/29
NCT04645810: A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Recruiting
N/A
12
US
High-Dose-Rate Brachytherapy
University of Rochester
Prostate Cancer, HDR
05/26
05/27
SCDB, NCT06422845: Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis

Recruiting
N/A
328
RoW
Dissolve AV Peripheral Scoring Drug-coated Balloon, Scoring Drug-coated Balloon
DK Medical Technology (Suzhou) Co., Ltd.
Arteriovenous Fistula Stenosis
07/27
07/27
TaLaR, NCT02966483: Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Recruiting
N/A
1114
RoW
TaTME, Transanal TME, LpTME, Laparoscopic TME
Sun Yat-sen University, Peking Union Medical College Hospital, The First Hospital of Jilin University, RenJi Hospital, Shengjing Hospital, The Second People's Hospital of Yibin, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Nanchong Central Hospital, Zunyi Medical College, The First Affiliated Hospital of University of South China, Xinqiao Hospital, Nanfang Hospital, Southern Medical University, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, Affiliated Hospital of Guangdong Medical University, The Third Xiangya Hospital of Central South University
Rectal Neoplasms Malignant, Surgery
07/26
07/26
mLOWER, NCT02693496: Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research

Recruiting
N/A
10000
RoW
Installation or registration of smartphone application
Chinese Alliance Against Lung Cancer
Solitary Pulmonary Nodule
10/25
10/25
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting
N/A
2150
RoW
Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Heart Disease
01/26
01/28
FLORA-01, NCT05730595: Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer

Not yet recruiting
N/A
550
RoW
lymph node dissection, Fluorescence-guided laparoscopic surgery, Radical operation for rectal cancer and sigmoid Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Fudan University, Fujian Province Tumor Hospital, Guangdong Provincial People's Hospital, Shengjing Hospital, Affiliated Hospital of Qinghai University, Hebei Medical University Fourth Hospital, The Second Affiliated Hospital of Harbin Medical University, Jiangxi Provincial Cancer Hospital, The First Hospital of Jilin University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanxi Province Cancer Hospital, Nanfang Hospital, Southern Medical University, Second People's Hospital of Yunnan Province, Binzhou Medical University, The First Affiliated Hospital of University of Science and Technology of China, First Affiliated Hospital of Chengdu Medical College, The Second People's Hospital of Yibin, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Colorectal Neoplasms, Fluorescence, Lymph Node Excision
12/26
06/27
TESTING-ON, NCT05434325: TESTING -ON Post-Trial ObservatioNal Cohort Study

Recruiting
N/A
366
Canada, RoW
The George Institute, Peking University Institute of Nephrology
IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases
07/27
07/27
Lu, Ying
FUMANBA-03, NCT06464991: A Phase III Study of Eque-cel in Subjects with Len-refractory RRMM

Recruiting
3
240
RoW
Equecabtagene Autoleucel Injection, FUCASO, Daratumumab, Pomalidomide, Bortezomib, Dexamethasone
Nanjing IASO Biotechnology Co., Ltd.
Multiple Myeloma
08/27
12/30
NCT06520176: Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients

Recruiting
3
99
RoW
Etoposide, VP-16, Cytarabine, Ara-C, Pegfilgrastim, PEG-rhG-CSF, Cyclophosphamide, Cy, G-CSF, Granulocyte Colony Stimulating Factor
The Affiliated People's Hospital of Ningbo University, First Affiliated Hospital of Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, The Central Hospital of Lishui City, Jinhua People's Hospital, Shaoxing People's Hospital, Shaoxing Second Hospital, Zhejiang Provincial Tongde Hospital, Taizhou Hospital, Dongyang People's Hospital, Affiliated Hospital of Jiaxing University, Huizhou Municipal Central Hospital, Second Affiliated Hospital of Wenzhou Medical University, Ningbo Medical Center Lihuili Hospital, Jinhua Municipal Central Hospital
Multiple Myeloma, Hematopoietic Stem Cell Mobilization
12/26
12/26
NCT06520163: Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

Recruiting
3
99
RoW
Etoposide, VP-16, Cytarabine, Ara-C, PEG-rhG-CSF, G-CSF, CHOP, Hyper-CVAD, ID-MTX + Ara-C, DA-EPOCH, GDP, GDPE, ICE, DICE
The Affiliated People's Hospital of Ningbo University, First Affiliated Hospital of Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Jinhua People's Hospital, The Central Hospital of Lishui City, Shaoxing People's Hospital, Shaoxing Second Hospital, Zhejiang Provincial Tongde Hospital, Taizhou Hospital, Dongyang People's Hospital, Affiliated Hospital of Jiaxing University, Huizhou Municipal Central Hospital, Second Affiliated Hospital of Wenzhou Medical University, Ningbo Medical Center Lihuili Hospital, Jinhua Municipal Central Hospital
Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization
12/26
12/26
TQ05105-III-01, NCT06682169: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

Recruiting
3
182
RoW
Rovadicitinib, Imatinib, Methotrexate, Mycophenolate mofetil, Rituximab
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Graft-versus-host Disease
10/29
12/30
NCT05780372: Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Recruiting
3
474
RoW
Intensity Modulated Radiation Therapy, IMRT, Chemotherapy
Sun Yat-sen University, Jiangxi Provincial Cancer Hospital, Zhejiang Cancer Hospital, Chongqing University Cancer Hospital, Dongguan People's Hospital, LiuZhou People's Hospital
Nasopharyngeal Carcinoma, Radiotherapy; Complications
05/25
05/28
NCT05084027: Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Recruiting
2
50
RoW
venetoclax combining with fludarabine and melphalan
First Affiliated Hospital of Zhejiang University, Sir Run Run Shaw Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial People's Hospital, The affiliated people's hospital of Ningbo University, First Affiliated Hospital of Wenzhou Medical University, Ningbo Hospital of Zhejiang University, The First Affiliated Hospital of Zhejiang Chinese Medical University
Hematologic Malignancy, Older Patients, Allogeneic Hematopoietic Stem Cell Transplantation
09/22
09/24
NCT06300320: A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Recruiting
2
52
RoW
TQ05105 tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Graft Versus Host Disease
10/25
04/26
NCT06455410: GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma

Recruiting
2
216
RoW
GP, Adebrelimab, concurrent chemoradiotherapy (CCRT)
Sun Yat-sen University
Nasopharyngeal Carcinoma
06/26
06/28
NCT03118986: RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Recruiting
2
200
Canada, US, RoW
Olanzapine, Placebo Oral Tablet
The Hospital for Sick Children, University of California, San Francisco, Children's Mercy Hospital Kansas City, St. Justine's Hospital, Columbia University, Medical University of South Carolina, CancerCare Manitoba, University of North Carolina, Chapel Hill, Nationwide Children's Hospital
Vomiting in Infants and/or Children, Nausea, Hematopoietic System--Cancer, Oncology
03/25
04/25
NCT05422066: Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma

Hourglass Jan 2023 - Dec 2023 : Market entry for endometrial cancer
Recruiting
2
50
RoW
Selinexor, ATG-010, Xpovio, Rituximab, RiTUXimab Injection, Cyclophosphamide, Cyclophosphamide Injection, Doxorubicin, Doxorubicin Hydrochloride, Vincristine, Vincristine Injection, Prednisone, Prednisone Oral Product
Li Zhiming, Antengene Corporation
DLBCL Germinal Center B-Cell Type
07/25
12/25
NCT05842512: Study of ADI-PEG 20 Versus Placebo in Subjects With NASH

Recruiting
2
40
RoW
ADI-PEG20, Pegargiminase, Placebo
Polaris Group
Nonalcoholic Steatohepatitis (NASH)
12/27
01/28
NCT02617407: Livionex Oral Microbiome and Dental Plaque Control in HSCT Recipients

Completed
1
44
US
Livionex® Dental Gel, Edathamil, PreviDent 5000 plus/Tom's of Maine Children's toothpaste, Over the counter toothpaste, Kolibree Toothbrush
University of California, San Francisco
Dental Plaque
01/20
01/20
NCT05528887: Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Recruiting
1
10
RoW
Autologous CAR-T cells, Fludarabine, Fludara, Cyclophosphamide, Cytoxan
The Affiliated People's Hospital of Ningbo University, UTC Therapeutics Inc.
Relapsed/Refractory Hematological Malignancies, Lymphoma, Myeloma, Leukemia
06/24
06/26
NCT06142175: Relmacabtagene Autoleucel in Patients With LBCL

Recruiting
N/A
200
RoW
Relmacabtagene Autoleucel, JWCAR029
Shanghai Ming Ju Biotechnology Co., Ltd.
Large B-cell Lymphoma
12/24
12/24
NCT05510089: Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies

Recruiting
N/A
62
RoW
Etoposide, VP-16, Cytarabine, Ara-C, PEG-rhG-CSF
The Affiliated People's Hospital of Ningbo University
Hematological Malignancy
05/24
12/24
2022-YAN-030, NCT05536154: Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

Recruiting
N/A
68
RoW
Etoposide, VP-16, Cytarabine, Ara-C, PEG-rhG-CSF
The Affiliated People's Hospital of Ningbo University
Lymphoma, Multiple Myeloma
06/24
10/24
NCT05589337: Baduanjin Training for Depression and Anxiety Patients

Recruiting
N/A
120
RoW
Baduanjin, Eight-section Brocade, Health education
Shanghai University of Traditional Chinese Medicine, Shanghai Mental Health Center
Depression Symptoms, Anxiety Symptoms
06/24
12/24
NCT05717790: Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Recruiting
N/A
288
RoW
Nimotuzumab, h-R3, BIOMAb EGFR, Gemcitabine, GEM, Cisplatin, DDP, Intensity-modulated radiotherapy, IMRT
Fourth Affiliated Hospital of Guangxi Medical University, People's Hospital of Baise, Second Affiliated Hospital of Guangzhou Medical University, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin Medical University, China, LiuZhou People's Hospital, The First People's Hospital of Qinzhou, Wuzhou Red Cross Hospital, Affiliated Hospital of Youjiang Medical University for Nationalities
Nasopharyngeal Carcinoma by AJCC V8 Stage
11/24
11/27
NCT04837222: A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

Active, not recruiting
N/A
1000
RoW
No Intervention
Takeda
Lymphoma
06/26
06/26
NCT05355675: The Association of Microbiota Composition With cGVHD After Allo-HSCT

Recruiting
N/A
300
RoW
blood sample, stool sample
First Affiliated Hospital of Zhejiang University
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy, Chronic Graft-versus-host-disease, Complication
05/25
05/25
NCT05940480: TCM Daoyin Therapy in Individuals At-risk for COPD

Recruiting
N/A
60
RoW
TCM Daoyin, Qigong, Health education
Shanghai University of Traditional Chinese Medicine, Changzheng Community Health Service Center of Putuo District, Shanghai
Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
06/27
12/27
Chen, Yundai
Health, NCT06187727: Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction

Recruiting
4
240
RoW
Henagliflozin
Qian geng
Myocardial Infarction, Heart Failure
10/24
10/24
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
539
RoW
BuMA Supreme, BuMA™
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
03/18
12/25
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
1000
RoW
BuMA Supreme
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
05/19
12/25
NCT04220437: Identification of Neoatherosclerosis in ISR Patients Based on Artifical Intelligence

Recruiting
N/A
90
RoW
no interventin
Chinese PLA General Hospital
In-stent Restenosis, Neo-atherosclerosis, Retrospective
01/21
02/21
NCT03574636: OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation

Recruiting
N/A
375
RoW
OCT guidance, IVUS guidance, QCA
Shanghai MicroPort Medical (Group) Co., Ltd.
Optical Coherence Tomography, Intravascular Ultrasound, Angiography
09/21
09/25
SUPERIOR, NCT04617899: The StUdy to Evaluate the Performance and safEty of the Novasight HybRid System Using Objective PeRformance Criteria

Recruiting
N/A
120
RoW
Intravascular imaging
CardioNavi MedTech (Wuhan) Co., Ltd., Beijing Jingruitianhe Medical Science and Technology Development Co,Ltd
Coronary Artery Disease
11/21
12/21
NCT04733443: The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis

Active, not recruiting
N/A
310
RoW
Biolimus, SeQuent® Please Neo
JW Medical Systems Ltd
Coronary Artery Disease
01/23
02/25
NCT04982588: Evolut PRO China Clinical Study

Active, not recruiting
N/A
52
RoW
Medtronic CoreValve™ Evolut™ PRO System
Medtronic Cardiovascular
Severe, Symptomatic Aortic Stenosis
03/23
05/28
NCT05580952: Clinical Trial in China

Recruiting
N/A
120
RoW
Transcatheter aortic valve replacement
Genesis Medtech Corporation
Diseases of Aortic Valve, Aortic Regurgitation Disease
05/23
05/24
NCT05607667: Clinical Trial in China for Aortic Valve Stenosis

Recruiting
N/A
53
RoW
Transcatheter aortic valve replacement
Genesis Medtech Corporation
Diseases of Aortic Valve, Aortic Stenosis Disease
05/23
05/23
NCT04722796: HANGZHOU Solution in Bicuspid AS Undergoing TAVR

Recruiting
N/A
508
RoW
TAVR with Venus A plus using supra-annular sizing and THV implantation technique (Hangzhou solution), Hangzhou solution, TAVR with Venus A plus using annular sizing and THV implantation technique, Traditional sizing strategy (Annulus based sizing strategy)
Second Affiliated Hospital, School of Medicine, Zhejiang University, Venus MedTech (HangZhou) Inc., First Affiliated Hospital Bengbu Medical College, Chinese PLA General Hospital, Fujian Medical University Union Hospital, Xiamen University Affiliated Cardiovascular Hospital, Guangdong People's Hospital, Zhengzhou Cardiovascular Hospital, The First Affiliated Hospital of Zhengzhou University, Hennan Provincial Chest Hospital, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Central South University, Northern Jiangsu Province People's Hospital, The First Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Nanchang University, The Affiliated Hospital of Qingdao University, Shanxi cardiovascular hospital, Tianjin Chest Hospital, Ning Bo First Hospital
Aortic Stenosis, Aortic Stenosis With Bicuspid Valve
04/24
04/28
NCT05454878: Atrial Fibrillation Monitoring on Patients With Lymphoma After Chemotherapy

Not yet recruiting
N/A
100
RoW
Chinese PLA General Hospital
Atrial Fibrillation
07/23
12/23
Wang, Yan
NCT06256289: Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

Not yet recruiting
4
50
NA
Canagliflozin 100mg Tab, Invokana, Metformin Hydrochloride, Glucophage
Ping Li,MD
Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease
04/25
04/25
NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Recruiting
3
450
RoW
camrelizumab + famitinib, pembrolizumab, camrelizumab
Jiangsu HengRui Medicine Co., Ltd.
Non-small Cell Lung Cancer
12/23
12/25
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Recruiting
3
522
RoW
D-1553 Tablet, Docetaxel injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
10/26
12/27
ASPIRE, NCT03907046: Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Recruiting
3
700
US
Apixaban, Eliquis, Aspirin
Yale University, National Institute of Neurological Disorders and Stroke (NINDS)
Intracerebral Hemorrhage, Atrial Fibrillation
04/27
04/27
SURPASS-CN-INS, NCT05691712: A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

Completed
3
257
RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Diabetes Type 2, Diabetes Mellitus, Glucose Metabolism Disorders, Metabolic Disease, Endocrine System Diseases
07/24
07/24
NCT06738979: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects

Not yet recruiting
3
408
RoW
TQF3510 (Semaglutide Injection), Wegovy®
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Obesity
07/26
08/26
TQB2450-AL2846-III-01, NCT05922345: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.

Recruiting
3
518
RoW
TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules, TQB2450 placebo, docetaxel injection, AL2846 matching placebo
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non-small Cell Lung Cancer
08/25
12/25
CAPTIVA, NCT05047172: Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Recruiting
3
1683
US
Ticagrelor + Aspirin, Brilinta, Rivaroxaban + Aspirin, Xarelto, Clopidogrel + Aspirin, Plavix, Risk Factor Management
University of Florida, National Institute of Neurological Disorders and Stroke (NINDS), University of Cincinnati, Medical University of South Carolina, Janssen Scientific Affairs, LLC, AstraZeneca
Intracranial Arteriosclerosis, Stroke
05/28
05/28
NCT04412564: A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor

Recruiting
2
200
RoW
TQ-B3101
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Malignant Tumor
03/21
09/21
NCT04228926: Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects

Recruiting
2
105
RoW
ZKY001 eye drops 0.3g:0.006mg, shengfatai-eye drops, the Germinal Peptide eye drops, ZKY001 eye drops 0.3g:0.012mg, ZKY001 simulated eye drops, the placebo
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Corneal Defect
12/21
12/21
NCT05148195: A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors

Terminated
2
86
RoW
Envofolimab, BD0801, Docetaxel, Irinotecan, Leucovorin calcium, 5-Fluorouridine
Jiangsu Simcere Pharmaceutical Co., Ltd.
Advanced Solid Tumor
07/23
07/23
NCT05420324: A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma

Completed
2
20
RoW
YH003, Pembrolizumab, albumin paclitaxel
Eucure (Beijing) Biopharma Co., Ltd
Mucosal Melanoma
03/24
03/24
NCT06439381: Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps

Recruiting
2
120
RoW
300mg/600mg of TQH2722 injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Rhinosinusitis
10/25
11/25
NCT06837233: A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis

Not yet recruiting
2
160
RoW
Pumecitinib Nasal Spray 0.3%, Pumecitinib Nasal Spray 0.6%, Placebo (twice daily), Pumecitinib nasal spray 0.6%(twice daily), Placebo
Prime Gene Therapeutics Co., Ltd.
Seasonal Allergic Rhinitis
07/25
01/26
NCT06089278: A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.

Recruiting
2
160
RoW
300mg of TQH2722 injection, 600mg of TQH2722 injection, TQH2722 injection matching placebo
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Sinusitis
05/25
05/25
NCT04993391: AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer

Recruiting
1/2
156
RoW
JS111(AP-L1898 Capsules)
Suzhou Junjing BioSciences Co., Ltd.
Lung Cancer
06/24
08/24
NCT04434482: IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer

Completed
1/2
59
US, RoW
IMP4297(senaparib), temozolomide
Impact Therapeutics, Inc.
Advanced Solid Tumours, Small Cell Lung Cancer
04/24
04/24
NCT05416775: Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer

Recruiting
1/2
168
RoW
SHR-8068;Adebrelimab, SHR-8068;adebrelimab and platinum-based chemotherapy, Adebrelimab;platinum-based chemotherapy
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Advanced Non-small Cell Lung Cancer
06/26
06/26
NCT05126927: A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors

Completed
1
11
RoW
68Ga-NODAGA-SNA006
SmartNuclide Biopharma, The First Affiliated Hospital of Soochow University
Solid Tumor
01/22
08/22
NCT04711980: Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy

Not yet recruiting
1
402
RoW
Mudan granule, Mudan particle, Placebo, Placebos
Fengmei Lian, Peking Union Medical College Hospital, Beijing Hospital, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Affiliated Hospital of Qingdao University, Chengdu University of Traditional Chinese Medicine, The Fourth People's Hospital of Chongqing, Zhengzhou Yihe Hospital Affiliated to Henan University, Zhu Xianyi Memorial Hospital of Tianjin Medical University, The Third Hospital of Xi'an, Huashan Hospital, Gansu Provincial People's Hospital, Shenzhen Hospital of Guangzhou University of Traditional Chinese Medicine, Affiliated Hospital of Changchun University of Chinese Medicine
Diabetic Peripheral Neuropathy Type 2
02/22
09/22
NCT05490264: [68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

Recruiting
1
20
RoW
[68Ga]Ga-NOTA-SNA002
SmartNuclide Biopharma, The First Affiliated Hospital of Soochow University
Solid Tumor, Positron-Emission Tomography(PET)
06/24
07/24
NCT03736343: Impulsivity and Alcohol Response

Terminated
1
24
US
Alcohol, 80-proof Vodka Mixed Drinks
University of Florida, National Institute on Alcohol Abuse and Alcoholism (NIAAA), American Psychological Association
Alcohol Use Disorder (AUD), Subjective Response to Alcohol (SR)
05/20
10/22
NCT06429241: Evaluate the Distribution and Dynamic Behavior of TH-SC01 Cells in Vivo in Patients With Perianal Fistula

Recruiting
1
8
RoW
Mesenchymal Stem Cells (MSCs)
Jiangsu Topcel-KH Pharmaceutical Co., Ltd., The First Affiliated Hospital of Soochow University
Anal Fistula, Complex Perianal Fistulas, Crohn's Disease
11/24
12/25
NCT06229301: A Study of Artificial Intelligence Assisted Small Incision Lenticule Extraction (SMILE) for Surgical Design and Influencing Factors

Recruiting
N/A
3000
RoW
AI-predicted Nomogram
Tianjin Eye Hospital, Beihang University
Myopia, Myopic Astigmatism
09/24
09/24
NCT04172168: Left Ventricular Free-wall Ruptrue After Acute Myocardial Infarction (LVFR-AMI)

Recruiting
N/A
17568
RoW
Heart rupture
Xiamen Cardiovascular Hospital, Xiamen University
Acute Myocardial Infarction
12/19
03/21
STMIK, NCT06233409: A Novel Sandwich Technique of Minimally Invasive Keratoplasty for Corneal Perforation

Recruiting
N/A
30
RoW
Tianjin Eye Hospital
Corneal Perforation, Corneal Stromal Lenticule,Sandwich Technique
12/24
12/24
NCT06211218: Artificial Intelligence for Screening of Multiple Corneal Diseases

Recruiting
N/A
3000
RoW
Cornea diseases diagnosed by artificial intelligence algorithm
Tianjin Eye Hospital
Deep Learning, Corneal Disease, Screening
12/21
12/24
NCT04667819: Wireless Micropump in Dry Eye Patients

Recruiting
N/A
20
RoW
Sodium Hyaluronate
Tianjin Eye Hospital, Tianjin University
Dry Eye
12/21
03/22
NCT05967702: A 3-year Cross-sectional Assessment of the Tianjin Child and Adolescent Large-scale Eye Study

Completed
N/A
126810
RoW
Tianjin Eye Hospital
Myopia
12/21
12/21
NCT06256770: Evaluation of the Safety and Efficacy of Rigid Breathable Scleral Contact Lenses for the Correction of Ametropia

Recruiting
N/A
176
RoW
Tianjin Eye Hospital
Ocular Surface Disease, Irregular Astigmatism, Contact Lens Complication, Corneal Astigmatism
09/24
12/24
NCT05748002: Evaluation of Morphology Abnormal Cornea Stability With Corneal Biomechanical

Completed
N/A
315
RoW
Pentacam and Corvis ST
Tianjin Eye Hospital
Keratoconus, Stable
12/22
12/22
 

Download Options